LDR gains expanded approval for spinal implant device; Chip mimics human capillaries;

@FierceMedDev: Sign up to receive our new publication FierceDiagnostics in your inbox each Wednesday. Sign up here | Follow @FierceMedDev

@DamianFierce: J&J is switching up its Chinese leadership as local authorities eye drug and device firms. News | Follow @DamianFierce

@MarkHFierce: The sleep apnea device industry is poised to get an infusion of a number of new treatments. ICYMI yesterday | Follow @MarkHFierce

> It's been quite a month for LDR: The company won FDA approval for its Mobi-C spinal implant and filed for a $69 million IPO, and now it has picked up another agency approval that expands the indications for the same device. News

> Medtronic's ($MDT) recent push into patient monitoring and disease management points to a difficult future for the world's traditional device companies, according to an analyst. News

> University of Washington scientists say they have crafted a device that allows for the first-ever human-to-human mind meld. Article

> Researchers at Lehigh University have developed a chip they say can mimic human capillaries and predict how cancer drugs will affect specific patients. Story

> Sphere Medical says it has made progress toward filing a CE mark for its new blood monitoring device. Item

> Allied Healthcare won a CE mark for its new regenerative tissue repair product to repair and reconstruct heart defects. Story

> ECRI is launching a faster iteration of its online notification system in order to help hospitals respond to medical product recalls faster. Story

Biotech News

@FierceBiotech: ICYMI from FierceCRO: PPD snags Acurian for recruitment software. News | Follow @FierceBiotech

@JohnCFierce: No Teva deal for Rexahn. Press release | Follow @JohnCFierce

@EmilyMFierce: This week's issue of FierceBiotech Research. Not subscribed? Sign up for free here. | Follow @EmilyMFierce

> Onyx spells out layoff policies as staffers brace for post-buyout cuts. More

> Cramer vs. Cramer: What's the next big biotech takeover target? News

> Gilead's sofosbuvir cures some of the toughest hepatitis C cases. Article

Pharma News

@FiercePharma: China arrests British consultant and wife for trafficking in private information. Pharma probe churns on… Yesterday's story | Follow @FiercePharma

@EricPFierce: Swiss CMO Siegfried building a manufacturing plant in China. ICYMI from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Eye-drug specialist Akorn buys rival Hi-Tech for $640M. Article | Follow @CarlyHFierce

> Onyx staffers to get word on layoffs 30 days after Amgen deal wraps. Story

> Simcere going private thanks to $495M buyout by chairman. Report

> Endo's Qualitest unit snags niche generics player for $225M. News

> J&J rejigs Chinese ops to centralize under local chairman. Article

Drug Delivery News

@MichaelGFierce: Ceptaris nets first-ever FDA approval for topical lymphoma chemo gel. Article | Follow @MichaelGFierce

> Chip lined with human cells tests cancer drug delivery with minimal cost. Story

> Singapore team makes 'nanocages' for protein drug delivery. Article

> Lipidor, Karolinska post sound PhI/IIa results for novel spray-on psoriasis drug. News

> Nano-gold's penetrating methods revealed in MIT, Swedish study. More

> FDA clears Novo Nordisk's insulin injection pen for children. Item

Diagnostics News

> U Texas group finds ovarian cancer Dx works better over time. More

> Harvard, Danish team develop new brain cancer MRI approach. Story

> Applied Proteomics mulls Alzheimer's companion Dx. Article

> Life Technologies loses exec to Dx startup. Item

> Exosome, Mount Sinai forge Dx development partnership. Report

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.